Breadcrumb AMCP.org Resource Center AMCP submits comments to Ohio House leadership, opposing HB 248, a bill concerning abuse-deterrent opioid analgesic drug products Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page 3/18/19 AMCP submits comments to Ohio House leadership, opposing HB 248, a bill concerning abuse-deterrent opioid analgesic drug products OH Sub HB 248.pdf Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page